AngioDynamics' latest acquisition will boost $95 million business line

It is the latest in a string of acquisitions for AngioDynamics as chief exec Jim Clemmer refocuses the medical device maker by "carving out significant space in larger and faster growing markets."
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news